CoChat

Prebiotic Effects of Xylooligosaccharides on the Improvement of Microbiota Balance in Human Subjects

Open access
Lin, Shyh-Hsiang, Chou, Liang-Mao, Chien, Yi-Wen, Chang, Jung-Su, Lin, Ching-I · 2016 · Gastroenterology Research and Practice

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

It has been indicated that probiotics can be nourished by consuming prebiotics in order to function more efficiently, allowing the bacteria to stay within a healthy balance. In this study, we investigated the effects of xylooligosaccharides- (XOS-) enriched rice porridge consumption on the ecosystem in the intestinal tract of human subjects. Twenty healthy subjects participated in this 6-week trial, in which 10 subjects received XOS-enriched rice porridge while the others received placebo rice porridge. Fecal samples were collected at the end of weeks 0, 1, 3, 4, 6, and 7 for microorganism examination. The results showed that 6-week daily ingestion of the XOS-enriched rice porridge induced significant increases in fecal bacterial counts of Lactobacillus spp. and Bifidobacterium spp., as well as decreases in Clostridium perfringens without changing the total anaerobic bacterial counts, compared to that of placebo rice porridge. However, fluctuations in the counts of coliforms were observed in both groups during the 6-week intervention. In conclusion, the intestinal microbiota balance was improved after daily consumption of 150 g of rice porridge containing XOS for 6 weeks, demonstrating the prebiotic potential of XOS incorporated into foods. This also indicates the effectiveness of XOS as a functional ingredient in relation to its role as a prebiotic compound.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2016/5789232

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The experiment timetable.
Figure 1 The experiment timetable.CC BY · PubMed Central
Figure 2 The changes in logarithm number (mean ± SD) of total anaerobic bacteria during the trial. Weeks 0-1: a run-in phase. Weeks 6-7: a 1-week washout phase.
Figure 2 The changes in logarithm number (mean ± SD) of total anaerobic bacteria during the trial. Weeks 0-1: a run-in phase. Weeks 6-7: a 1-week washout phase.CC BY · PubMed Central
Figure 3 The changes in logarithm number (mean ± SD) of Lactobacillus spp. during the trial. Weeks 0-1: a run-in phase. Weeks 6-7: a 1-week washout phase. #Repeated measures ANOVA on different groups across time. ∗Paired t-test of week 6 versus week 0 within a group. p < 0.05.
Figure 3 The changes in logarithm number (mean ± SD) of Lactobacillus spp. during the trial. Weeks 0-1: a run-in phase. Weeks 6-7: a 1-week washout phase. #Repeated measures ANOVA on different groups across time. ∗Paired t-test of week 6 versus week 0 within a group. p < 0.05.CC BY · PubMed Central
Figure 4 The changes in logarithm number (mean ± SD) of Bifidobacterium spp. during the trial. Weeks 0-1: a run-in phase. Weeks 6-7: a 1-week washout phase. #Repeated measures ANOVA on different groups across time. ∗Paired t-test of week 6 versus week 0 within a group. p < 0.05.
Figure 4 The changes in logarithm number (mean ± SD) of Bifidobacterium spp. during the trial. Weeks 0-1: a run-in phase. Weeks 6-7: a 1-week washout phase. #Repeated measures ANOVA on different groups across time. ∗Paired t-test of week 6 versus week 0 within a group. p < 0.05.CC BY · PubMed Central
Figure 5 The changes in logarithm number (mean ± SD) of coliforms during the trial. Weeks 0-1: a run-in phase. Weeks 6-7: a 1-week washout phase. #Repeated measures ANOVA on different groups across time. p < 0.05.
Figure 5 The changes in logarithm number (mean ± SD) of coliforms during the trial. Weeks 0-1: a run-in phase. Weeks 6-7: a 1-week washout phase. #Repeated measures ANOVA on different groups across time. p < 0.05.CC BY · PubMed Central
Figure 6 The changes in logarithm number (mean ± SD) of Clostridium perfringens during the trial. Weeks 0-1: a run-in phase; Weeks 6-7: a 1-week washout phase. #Repeated measures ANOVA on different groups across time. ∗Paired t-test of week 6 versus week 0 within a group. p < 0.05.
Figure 6 The changes in logarithm number (mean ± SD) of Clostridium perfringens during the trial. Weeks 0-1: a run-in phase; Weeks 6-7: a 1-week washout phase. #Repeated measures ANOVA on different groups across time. ∗Paired t-test of week 6 versus week 0 within a group. p < 0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

Items 101–147 of 147

Metadata

Authors
Lin, S.-H., Chou, L.-M., Chien, Y.-W., Chang, J.-S., & Lin, C.-I.
Affiliations
  • Taipei Medical University (TW)
  • Taipei Veterans General Hospital (TW)
  • Kainan University (TW)
Corresponding author
Lin, Ching-I
Venue
Gastroenterology Research and Practice
Publisher
Wiley
Published
2016
Volume
2016
Pages
1-6
ISSN
  • 1687-6121 (ISSN-L)
  • 1687-630X
OpenAlex
W2516023307
Cited by
135
References
27
Citations by year
2026: 16 · 2025: 13 · 2024: 16 · 2023: 14 · 2022: 14 · 2021: 17 · 2020: 16 · 2019: 9 · 2018: 17 · 2017: 1 · 2016: 2
FWCI
10.12
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology Research and Practice (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
xylooligosaccharides, prebiotics, gut microbiota, rice porridge, Lactobacillus, Bifidobacterium, Clostridium perfringens, coliform bacteria, functional food ingredients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.